FEMASYS INC (FEMY)
FEMASYS INC (FEMY)
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 5,386,041 | 9,266,353 | 4,569,038 | 3,218,067 |
| Accounts receivable, net | 172,264 | 616,600 | 572,199 | 254,584 |
| Inventory | 6,105,267 | 5,740,249 | 5,783,974 | 5,232,738 |
| Prepaid and other current assets | 679,917 | 833,133 | 1,321,689 | 1,045,591 |
| Total current assets | 12,343,489 | 16,456,335 | 12,246,900 | 9,750,980 |
| Leasehold improvements | 1,238,886 | 1,238,886 | 1,238,886 | 1,238,886 |
| Office equipment | 80,941 | 78,155 | 78,155 | 68,530 |
| Furniture and fixtures | 421,798 | 417,876 | 417,876 | 417,876 |
| Machinery and equipment | 3,095,633 | 3,065,713 | 3,283,672 | 3,211,109 |
| Construction in progress | 955,271 | 897,885 | 687,462 | 548,426 |
| Property and equipment, gross | 5,792,529 | 5,698,515 | 5,706,051 | 5,484,827 |
| Less accumulated depreciation | 3,868,518 | 3,802,940 | 3,956,987 | 3,884,964 |
| Net property and equipment | 1,924,011 | 1,895,575 | 1,749,064 | 1,599,863 |
| Lease right-of-use assets, net | 1,178,941 | 1,297,121 | 1,419,345 | 1,544,724 |
| Intangible assets, net of accumulated amortization | 124,252 | 134,914 | 130,041 | 55,638 |
| Other long-term assets | 924,552 | 940,232 | 744,803 | 829,204 |
| Total long-term assets | 2,227,745 | 2,372,267 | 2,294,189 | 2,429,566 |
| Total assets | 16,495,245 | 20,724,177 | 16,290,153 | 13,780,409 |
| Convertible notes payable, net (including related parties) | NaN | 0 | NaN | 6,080,813 |
| Accounts payable | 1,597,591 | 1,830,124 | 2,173,883 | 3,263,584 |
| Accrued expenses | 1,024,706 | 1,265,773 | 1,028,461 | 1,052,752 |
| Clinical holdback current portion | 52,572 | 52,644 | 60,543 | 63,990 |
| Operating lease liabilities current portion | 480,286 | 487,624 | 494,954 | 502,468 |
| Total current liabilities | 3,155,155 | 3,636,165 | 10,541,684 | 10,963,607 |
| Clinical holdback long-term portion | 54,487 | 52,370 | 43,955 | 40,348 |
| Note payable | NaN | NaN | 276,489 | NaN |
| Convertible notes payable, net | 3,335,176 | 3,178,864 | 6,507,354 | NaN |
| Conversion option liability | 488,000 | 2,014,000 | NaN | NaN |
| Warrants liabilities | 1,260,000 | 4,943,000 | NaN | NaN |
| Operating lease liabilities long-term portion | 912,534 | 1,030,476 | 1,148,263 | 1,269,019 |
| Total long-term liabilities | 6,050,197 | 11,218,710 | 1,192,218 | 1,309,367 |
| Total liabilities | 9,205,352 | 14,854,875 | 11,733,902 | 12,272,974 |
| Common stock, 0.001 par, 200,000,000 authorized, 60,507,909 shares issued and 60,390,686 outstanding as of march 31, 2026 and 59,720,010 shares issued and 59,602,787 outstanding as of december 31, 2025 | 60,508 | 59,720 | 47,420 | 32,693 |
| Treasury stock, 117,223 common shares | 60,000 | 60,000 | 60,000 | 60,000 |
| Warrants | 5,246,150 | 5,246,150 | 6,727,334 | 1,821,744 |
| Additional paid in-capital | 147,023,279 | 146,449,576 | 139,717,336 | 137,394,016 |
| Accumulated deficit | -144,980,044 | -145,826,144 | -141,875,839 | -137,681,018 |
| Total stockholders equity | 7,289,893 | 5,869,302 | 4,556,251 | 1,507,435 |
| Total liabilities and stockholders' equity | 16,495,245 | 20,724,177 | 16,290,153 | 13,780,409 |